Fig 2. Receiver operating characteristic curves were used to determine the cutoff score for Ano1 overexpression in breast cancer.
The sensitivity and specificity for each outcome were plotted and the areas under curve (AUCs) and p value were indicated. A. Histological grade; B. Clinical stages; C. ER status; D. PR status; E. HER2 status; F. TNBC status; G. OS; H. Tamoxifen treatment.